New hope for tough cancers: experimental drug IMGS-001 enters human trials
Disease control
Recruiting now
This early-stage study tests an experimental drug called IMGS-001 in about 105 people with advanced solid tumors that have come back or not improved after standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. The study has two parts: first, t…
Phase: PHASE1 • Sponsor: ImmunoGenesis • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC